Featured Story First Effective Treatment for Transthyretin Amyloidosis
Johns Hopkins research into rare disease leads to approval of the first drug that can halt its progression.
Articles in this Issue
-
Uniting Basic and Applied Science for Ovarian Cancer
New Johns Hopkins-led SPORE helps speed translation from the lab to the clinic.
-
Addressing Cognitive Problems That Arise from Cancer Treatment
Two intervention studies find that noninvasive brain stimulation may improve cognitive problems that can occur following chemotherapy, radiation and other treatments.
-
Reducing Inflammation After Heart Attacks May Prevent Secondary Events
A treatment normally reserved for patients with stubbornly high low-density lipoprotein (LDL) cholesterol offers promise to reduce inflammation after heart attacks.
